Inventor · disambiguated record
Xiao-Tao Chen
Also filed as: CHEN XIAO · CHEN XIAO-TAO
47 granted patents·8 pending applications·813 citations·filing 1995–2021
98Inventor score
Top patents by PatentIndex Score
55 records- 0197US8835488B2Opioid receptor ligands and methods of using and making sameYAMASHITA DENNIS·Filed 2012·Granted Sep 16, 2014·41 cites·22 claims
- 0296US7439246B2Fused heterocyclic kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Oct 21, 2008·30 cites·31 claims
- 0396US5795894APiperazino derivatives as neurokinn antagonistsSCHERING CORP·Filed 1996·Granted Aug 18, 1998·109 cites·8 claims
- 0495US9849119B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2017·Granted Dec 26, 2017·6 cites·36 claims
- 0595US9309234B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2015·Granted Apr 12, 2016·7 cites·31 claims
- 0694US9642842B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2016·Granted May 9, 2017·6 cites·33 claims
- 0794US6635630B2Selective neurokinin antagonistsSCHERING CORP·Filed 2002·Granted Oct 21, 2003·41 cites·9 claims
- 0894US5968929APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1997·Granted Oct 19, 1999·70 cites·6 claims
- 0993US5869488APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1996·Granted Feb 9, 1999·78 cites·6 claims
- 1092US5798359APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1995·Granted Aug 25, 1998·56 cites·12 claims
- 1192US5719156APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1995·Granted Feb 17, 1998·55 cites·12 claims
- 1291US9044469B2Opioid receptor ligands and methods of using and making sameYAMASHITA DENNIS·Filed 2013·Granted Jun 2, 2015·5 cites·26 claims
- 1391US7511062B2Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitorsSCHERING CORP·Filed 2005·Granted Mar 31, 2009·31 cites·29 claims
- 1491US7173031B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 6, 2007·25 cites·18 claims
- 1589US8809260B2β-arrestin effectors and compositions and methods of use thereofTREVENA INC·Filed 2013·Granted Aug 19, 2014·7 cites·16 claims
- 1689US8486885B2β-arrestin effectors and compositions and methods of use thereofYAMASHITA DENNIS·Filed 2009·Granted Jul 16, 2013·7 cites·20 claims
- 1788US11077098B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2017·Granted Aug 3, 2021·2 cites·20 claims
- 1887US7547782B2Met kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 16, 2009·6 cites·17 claims
- 1987US6740649B2Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2002·Granted May 25, 2004·31 cites·49 claims
- 2087US6436928B1Selective neurokinin antagonistsSCHERING CORP·Filed 2000·Granted Aug 20, 2002·17 cites·23 claims
- 2185US8796204B2β-arrestin effectors and compositions and methods of use thereofTREVENA INC·Filed 2013·Granted Aug 5, 2014·4 cites·20 claims
- 2285US6995181B2Modulators of the glucocorticoid receptor and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 7, 2006·23 cites·28 claims
- 2383US9534017B2Beta-arrestin effectors and compositions and methods of use thereofTREVENA INC·Filed 2014·Granted Jan 3, 2017·3 cites·19 claims
- 2483US7763623B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2007·Granted Jul 27, 2010·9 cites·39 claims
- 2582US7160856B2α-O-linked glycoconjugates, methods of preparation and uses thereofSLOAN KETTERING INST CANCER·Filed 2002·Granted Jan 9, 2007·17 cites·47 claims
- 2680US8993511B2β-arrestin effectors and compositions and methods of use thereofTREVENA INC·Filed 2014·Granted Mar 31, 2015·2 cites·25 claims
- 2780US8946142B2Beta-arrestin effectors and compositions and methods of use thereofTREVENA INC·Filed 2013·Granted Feb 3, 2015·3 cites·19 claims
- 2880US7956189B2Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process thereforeSCHERING CORP·Filed 2007·Granted Jun 7, 2011·7 cites·10 claims
- 2979US11931350B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2021·Granted Mar 19, 2024·0 cites·20 claims
- 3079US7723342B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2006·Granted May 25, 2010·4 cites·61 claims
- 3179US7354922B2Bridged ring NK1 antagonistsSCHERING CORP·Filed 2005·Granted Apr 8, 2008·4 cites·30 claims
- 3279US6660714B1α-O-linked glycoconjugates, methods of preparation and uses thereofSLOAN KETTERING INST CANCER·Filed 1998·Granted Dec 9, 2003·36 cites·58 claims
- 3378US7737155B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2007·Granted Jun 15, 2010·2 cites·35 claims
- 3476US7211671B2Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 1, 2007·15 cites·12 claims
- 3574US7750015B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2006·Granted Jul 6, 2010·2 cites·47 claims
- 3674US6051575APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1999·Granted Apr 18, 2000·15 cites·8 claims
- 3773US10588898B2Opioid receptor ligands and methods of using and making sameTREVENA INC·Filed 2019·Granted Mar 17, 2020·0 cites·17 claims
- 3872US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 3972US6825215B21,1-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 30, 2004·5 cites·15 claims
- 4071US5981520APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1998·Granted Nov 9, 1999·13 cites·7 claims
- 4165US8283360B2Bicyclic heterocyclic derivatives and methods of use thereofPALANI ANANDAN·Filed 2009·Granted Oct 9, 2012·1 cites·2 claims
- 4262US6720329B2Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA·Filed 2002·Granted Apr 13, 2004·1 cites·28 claims
- 4362US2017298094A1Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofTREVENA INC·Filed 2016·Application pending·0 cites
- 4457US5892039APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1996·Granted Apr 6, 1999·13 cites·1 claims
- 4557US2015166604A1Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofTREVENA INC·Filed 2015·Application pending·0 cites
- 4655US2015105316A1Beta-Arrestin Effectors And Compositions And Methods Of Use ThereofTREVENA INC·Filed 2014·Application pending·0 cites
- 4752US6962938B2Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Nov 8, 2005·0 cites·19 claims
- 4849US2005171136A1Modulators of the glucocorticoid receptor and methodFiled 2005·Application pending·0 cites
- 4948US2010227873A1Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2010·Application pending·0 cites
- 5045US10836706B2Bacterial efflux pump inhibitorsUNIV RUTGERS·Filed 2017·Granted Nov 17, 2020·0 cites·19 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xiao-Tao Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →